DMN Market Analysis

Fundamentals

Updated daily after market close
P/E ratio0.00
EPS (TTM)$0.740.0% YoY
Profit margin2723.0%CONSUMER CYCLICAL
Market cap$4.2MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
84.12
EV/EBITDA
0.53

Profitability & growth

ROE (TTM)
0.0%
Operating margin
-6820.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
Last earnings
Dec 31, 2024 · Reported $1.40
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Damon Inc. Common Stock

Company profile

Damon Inc. (Ticker: DMN) is a forward-looking company in the healthcare diagnostics sector, focused on delivering cutting-edge solutions for disease detection and management. The firm harnesses proprietary technologies to produce a diverse array of diagnostic products, emphasizing improved patient outcomes. Positioned strategically to meet the surging demand for reliable and prompt diagnostic tools, Damon Inc. is backed by a vigorous pipeline of R&D initiatives. As the company expands its product lines and enhances its market reach, it aims to solidify its status as a key player in the…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
704 ALEXANDER STREET, VANCOUVER, BC
Fiscal year end
June
Latest quarter
Dec 31, 2024
Market cap$4.2M
Shares outstanding$2.45B
52W high$0.00
52W low$0.00

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer